{
    "references": [
        {
            "bibentry": "Ready, PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol 2014; 6: 147–54. PMID: 24833919",
            "process_entry": "True",
            "doi": "10.2147/CLEP.S44267",
            "pmid": "24833919",
            "pmcid": "PMC4014360",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Nagle, AS, Khare, S, Kumar, AB, et al. Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis. Chem Rev 2014; 114: 11305–47. PMID: 25365529",
            "process_entry": "True",
            "doi": "10.1021/cr500365f",
            "pmid": "25365529",
            "pmcid": "PMC4633805",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Croft, SL, Barrett, MP, Urbina, JA. Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 2005; 21: 508–12. PMID: 16150644",
            "process_entry": "True",
            "doi": "10.1016/j.pt.2005.08.026",
            "pmid": "16150644",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Croft, SL, Olliaro, P. Leishmaniasis chemotherapy—challenges and opportunities. Clin Microbiol Infect 2011; 17: 1478–83. PMID: 21933306",
            "process_entry": "True",
            "doi": "10.1111/j.1469-0691.2011.03630.x",
            "pmid": "21933306",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "De Menezes, JPB, Guedes, CES, De Oliveira, AL, et al. Advances in development of new treatment for leishmaniasis. Biomed Res Int 2015; 2015: 15–18.",
            "process_entry": "True",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Field, MC, Horn, D, Fairlamb, AH, et al. Antitrypanosomatid drug discovery: an ongoing challenge and a continuing need. Nat Rev Microbiol 2017; 15: 217–31. PMID: 28239154",
            "process_entry": "True",
            "doi": "10.1038/nrmicro.2016.193",
            "pmid": "28239154",
            "pmcid": "PMC5582623",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Cardoso, VS, Vermelho, AB, Ricci Junior, E, et al. Antileishmanial activity of sulphonamide nanoemulsions targeting the b-carbonic anhydrase from Leishmania species. J Enzym Inhib Med Chem 2018; 33: 850–7.",
            "process_entry": "True",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Nocentini, A, Cadoni, R, Dumy, P, et al. Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles. J Enzyme Inhib Med Chem 2018; 55: 286–9.",
            "process_entry": "True",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Vermelho, AB, Capaci, GR, Rodrigues, IA, et al. Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets. Bioorg Med Chem 2017; 25: 1543–55. PMID: 28161253",
            "process_entry": "True",
            "doi": "10.1016/j.bmc.2017.01.034",
            "pmid": "28161253",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Garcia, AR, Oliveira, DMP, Amaral, ACF, et al. Leishmania infantum arginase: biochemical characterization and inhibition by naturally occurring phenolic substances. J Enzyme Inhib Med Chem 2019; 34: 1100–9. PMID: 31124384",
            "process_entry": "True",
            "doi": "10.1080/14756366.2019.1616182",
            "pmid": "31124384",
            "pmcid": "PMC6534257",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Adinehbeigi, K, Razi Jalali, MH, Shahriari, A, Bahrami, S. In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum. Pathog Glob Health 2017; 111: 176–85. PMID: 28385129",
            "process_entry": "True",
            "doi": "10.1080/20477724.2017.1312777",
            "pmid": "28385129",
            "pmcid": "PMC5498762",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Martin-Montes, A, Santivañez-Veliz, M, Moreno-Viguri, E, et al. In vitro antileishmanial activity and iron superoxide dismutase inhibition of arylamine Mannich base derivatives. Parasitology 2017; 114: 1783–90.",
            "process_entry": "True",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Martínez, VC, Vera, M. Therapeutic potential of pteridine derivatives: a comprehensive review. Med Res Rev 2018; 1–56.",
            "process_entry": "True",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Linciano, P, Dawson, A, Po, I, et al. Exploiting the 2 –Amino-1,3,4-thiadiazole scaffold to inhibit Trypanosoma brucei pteridine reductase in support of early-stage drug discovery. ACS Omega 2017; 2: 5666–83. PMID: 28983525",
            "process_entry": "True",
            "doi": "10.1021/acsomega.7b00473",
            "pmid": "28983525",
            "pmcid": "PMC5623949",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Leite, FHA, Santiago, PBG, da, S, Froes, TQ, et al. Structure-guided discovery of thiazolidine-2,4-dione derivatives as a novel class of Leishmania major pteridine reductase 1 inhibitors. Eur J Med Chem 2016; 123: 639–48. PMID: 27517809",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2016.07.060",
            "pmid": "27517809",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Romero, AH, Rodríguez, N, Oviedo, H. 2-Aryl-quinazolin-4 (3 H) -ones as an inhibitor of leishmania folate pathway: in vitro biological evaluation, mechanism studies and molecular docking. Bioorganic Chemistry 2019; 83: 145–53. PMID: 30359795",
            "process_entry": "True",
            "doi": "10.1016/j.bioorg.2018.10.028",
            "pmid": "30359795",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Vickers, TJ, Beverley, SM. Folate metabolic pathways in Leishmania. Essays Biochem 2011; 51: 63–80. PMID: 22023442",
            "process_entry": "True",
            "doi": "10.1042/bse0510063",
            "pmid": "22023442",
            "pmcid": "PMC3278214",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Gatton, ML, Martin, LB, Cheng, Q. Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum. Antimicrob Agents Chemother 2004; 48: 2116–23. PMID: 15155209",
            "process_entry": "True",
            "doi": "10.1128/AAC.48.6.2116-2123.2004",
            "pmid": "15155209",
            "pmcid": "PMC415611",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Sharma, D, Lather, M, Mallick, PK, et al. Polymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of India. Parasit and Vectors [Internet] 2015; 8: 1–9.",
            "process_entry": "True",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Munita, JM, Arias, CA. Mechanisms of antibiotic resistance. Microbiol Spectr 2016; 4: 80–7.",
            "process_entry": "True",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Ivanetich, K, Santi, D Thymidylate synthase-dihydrofolate reductase in protozoa. Exp Parasitol. 1990; 70(3): 367–71.",
            "process_entry": "True",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Nare, B, Luba, J, Hardy, LW, Beverley, S. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity. Parasitology 1997; 114: S101–S10. PMID: 9309772",
            "process_entry": "True",
            "pmid": "9309772",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Luba, J, Nare, B, Liang, PH, et al. Leishmania major pteridine reductase 1 belongs to the short chain dehydrogenase family: stereochemical and kinetic evidence. Biochemistry 1998; 37: 4093–104. PMID: 9521731",
            "process_entry": "True",
            "doi": "10.1021/bi972693a",
            "pmid": "9521731",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Hardy, LW, Matthews, W, Nare, B, Beverley, SM. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways. Exp Parasitol 1997; 87: 157–69. PMID: 9371081",
            "process_entry": "True",
            "doi": "10.1006/expr.1997.4207",
            "pmid": "9371081",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Leite, FHA, Froes, TQ, da Silva, SG, et al. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors. Eur J Med Chem 2017; 132: 322–32. PMID: 28407565",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2017.03.043",
            "pmid": "28407565",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Barrack, KL, Tulloch, LB, Burke, LA, et al. Structure of recombinant Leishmania donovani pteridine reductase reveals a disordered active site. Acta Crystallogr Sect F Struct Biol Cryst Commun 2011; 67: 33–7.",
            "process_entry": "True",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Teles, ALB, Silva, RR, Ko, M, et al. Identification, characterization and molecular modelling studies of Schistosoma mansoni dihydrofolate reductase inhibitors: from assay development to hit identification. Curr Top Med Chem 2018; 18: 406–17. PMID: 29741139",
            "process_entry": "True",
            "doi": "10.2174/1568026618666180509150134",
            "pmid": "29741139",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Sambrook, J, Russel, D. Molecular cloning. 3rd ed. New York: Cold Spring Harbor Laboratory; 2001.",
            "process_entry": "True",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Bradford, MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54. PMID: 942051",
            "process_entry": "True",
            "doi": "10.1006/abio.1976.9999",
            "pmid": "942051",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Wingfield, PT. Protein precipitation using ammonium sulfate. Curr Protoc Protein Sci 2001;Appendix–3F:1–10.",
            "process_entry": "True",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Meek, TD, Garvey, EP, Santi, DV. Purification and characterization of the bifunctional thymidylate synthetase-dihydrofolate reductase from methotrexate-resistant Leishmania tropica. Biochemistry 1985; 24: 678–86. PMID: 3922404",
            "process_entry": "True",
            "doi": "10.1021/bi00324a021",
            "pmid": "3922404",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Dawson, A, Gibellini, F, Sienkiewicz, N, et al. Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate. Mol Microbiol 2006; 61: 1457–68. PMID: 16968221",
            "process_entry": "True",
            "doi": "10.1111/j.1365-2958.2006.05332.x",
            "pmid": "16968221",
            "pmcid": "PMC1618733",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Copeland, RA. Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists. 1st ed. United States of America: Wiley-interscience; 2005.",
            "process_entry": "True",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Kumar, P, Kothari, H, Singh, N. Overexpression in Escherichia coli and purification of pteridine reductase (PTR1) from a clinical isolate of Leishmania donovani. Protein Expr Purif 2004; 38: 228–36. PMID: 15555938",
            "process_entry": "True",
            "doi": "10.1016/j.pep.2004.08.015",
            "pmid": "15555938",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "Booth, WT, Schlachter, CR, Pote, S, et al. Impact of an N-terminal polyhistidine tag on protein thermal stability. ACS Omega 2018; 3: 760–8. PMID: 29399652",
            "process_entry": "True",
            "doi": "10.1021/acsomega.7b01598",
            "pmid": "29399652",
            "pmcid": "PMC5793033",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Gourley, DG, Luba, J, Hardy, LW, et al. Crystallization of recombinant Leishmania major pteridine reductase 1 (PTR1). Acta Crystallogr Sect D Biol Crystallogr 1999; 55: 1608–10. PMID: 10489462",
            "process_entry": "True",
            "doi": "10.1107/s0907444999008999",
            "pmid": "10489462",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Osorio, E, Aguilera, C, Naranjo, N, et al. Biochemical characterization of the bifunctional enzyme dihydrofolate reductase-thymidylate synthase from Leishmania (Viannia) and its evaluation as a drug target. Biomedica 2013; 33: 393–401. PMID: 24652175",
            "process_entry": "True",
            "doi": "10.7705/biomedica.v33i3.1434",
            "pmid": "24652175",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "Senkovich, O, Schormann, N, Chattopadhyay, D. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate. Acta Crystallogr Sect D Biol Crystallogr 2009; 65: 704–16. PMID: 19564691",
            "process_entry": "True",
            "doi": "10.1107/s090744490901230x",
            "pmid": "19564691",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "Grumont, R, Sirawaraporn, W, Santi, DV. Heterologous expression of the bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania major. Biochemistry 1988; 27: 3776–84. PMID: 2841973",
            "process_entry": "True",
            "doi": "10.1021/bi00410a039",
            "pmid": "2841973",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Ferrer, M, Chernikova, TN, Yakimov, MM, et al. Chaperonins govern growth of Escherichia coli at low temperatures. Nat Biotechnol 2003; 21: 1266–7. PMID: 14595348",
            "process_entry": "True",
            "doi": "10.1038/nbt1103-1266",
            "pmid": "14595348",
            "xmlid": "CIT0040"
        },
        {
            "bibentry": "Reche, P, Arrebola, R, Olmo, A, et al. Cloning and expression of the dihydrofolate reductase-thymidylate synthase gene from Trypanosoma cruzi. Mol Biochem Parasitol 1994; 65: 247–58. PMID: 7969266",
            "process_entry": "True",
            "doi": "10.1016/0166-6851(94)90076-0",
            "pmid": "7969266",
            "xmlid": "CIT0041"
        },
        {
            "bibentry": "Gibson, MW, Dewar, S, Ong, HB, et al. Trypanosoma brucei DHFR-TS revisited: characterisation of a bifunctional and highly unstable recombinant dihydrofolate reductase-thymidylate synthase. PLoS Negl Trop Dis 2016; 10: e0004714–20. PMID: 27175479",
            "process_entry": "True",
            "doi": "10.1371/journal.pntd.0004714",
            "pmid": "27175479",
            "pmcid": "PMC4866688",
            "xmlid": "CIT0042"
        },
        {
            "bibentry": "Bisswanger, H. Enzyme assays. Perspectives Sci. 2014; 1(1): 41–55.",
            "process_entry": "True",
            "xmlid": "CIT0043"
        },
        {
            "bibentry": "Glaser, TA, Baatz, JE, Kreishman, GP, Mukkada, AJ. pH homeostasis in Leishmania donovani amastigotes and promastigotes. Proc Natl Acad Sci USA 1988; 85: 7602–6. PMID: 3174653",
            "process_entry": "True",
            "doi": "10.1073/pnas.85.20.7602",
            "pmid": "3174653",
            "pmcid": "PMC282240",
            "xmlid": "CIT0044"
        },
        {
            "bibentry": "Yu, PL, Zhao, J, Yu, M, et al. Functional expression of the dihydrofolate reductase domain of Leishmania major dihydrofolate reductase-thymidylate synthase bifunctional protein. Protein Expr Purif 1996; 8: 23–7. PMID: 8812831",
            "process_entry": "True",
            "doi": "10.1006/prep.1996.0070",
            "pmid": "8812831",
            "xmlid": "CIT0045"
        },
        {
            "bibentry": "Tahar, R, De Pécoulas, PE, Basco, LK, et al. Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli. Mol Biochem Parasitol 2001; 113: 241–9. PMID: 11295178",
            "process_entry": "True",
            "doi": "10.1016/s0166-6851(01)00230-4",
            "pmid": "11295178",
            "xmlid": "CIT0046"
        },
        {
            "bibentry": "Pattanakitsakul, S, Ruenwongsa, P. Characterization of thymidylate synthetase and dihydrofolate reductase from Plasmodium berghei. Int J Parasitol 1984; 14: 513–20. PMID: 6392123",
            "process_entry": "True",
            "doi": "10.1016/0020-7519(84)90033-x",
            "pmid": "6392123",
            "xmlid": "CIT0047"
        },
        {
            "bibentry": "Beard, WA, Appleman, JR, Delcamp, TJ, et al. The wide range of rates exhibited. J Biol 1989; 264: 9391–9.",
            "process_entry": "True",
            "xmlid": "CIT0048"
        },
        {
            "bibentry": "Liu, CT, Francis, K, Layfield, JP, et al. Escherichia coli dihydrofolate reductase catalyzed proton and hydride transfers: temporal order and the roles of Asp27 and Tyr100. Proc Natl Acad Sci 2014; 111: 18231–6. PMID: 25453098",
            "process_entry": "True",
            "doi": "10.1073/pnas.1415940111",
            "pmid": "25453098",
            "pmcid": "PMC4280594",
            "xmlid": "CIT0049"
        },
        {
            "bibentry": "Acker, MG, Auld, DS. Considerations for the design and reporting of enzyme assays in high-throughput screening applications. Perspect Sci 2014; 1: 56–73.",
            "process_entry": "True",
            "xmlid": "CIT0050"
        },
        {
            "bibentry": "Liang, PH, Anderson, KS. Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase. Biochemistry 1998; 37: 12195–205. PMID: 9724533",
            "process_entry": "True",
            "doi": "10.1021/bi9803168",
            "pmid": "9724533",
            "xmlid": "CIT0051"
        },
        {
            "bibentry": "Copeland, RA. Enzymes-a practical introduction to structure. 2nd ed New York: J Wiley-Interscience; 2000.",
            "process_entry": "True",
            "xmlid": "CIT0052"
        },
        {
            "bibentry": "Kaur, J, Sundar, S, Singh, N. Molecular docking, structure–activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani. Antimicro Agents Chemother 2010; 65: 1742–8.",
            "process_entry": "True",
            "xmlid": "CIT0053"
        },
        {
            "bibentry": "Kaur, J, Kumar, P, Tyagi, S, et al. In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis. Antimicro Agents Chemother 2011; 55: 659–66.",
            "process_entry": "True",
            "xmlid": "CIT0054"
        },
        {
            "bibentry": "Chang, C, Bray, T, Whiteley, JM. Mutant PTR1 proteins from L eishmania tarentolae: comparative kinetic properties and active-site labeling. Arch Biochem Biophys. 1999; 368: 161–71. PMID: 10415124",
            "process_entry": "True",
            "doi": "10.1006/abbi.1999.1290",
            "pmid": "10415124",
            "xmlid": "CIT0055"
        },
        {
            "bibentry": "Nare, B, Hardy, LW, Stephen, M, et al. The roles of pteridine reductase 1 and synthase in pteridine metabolism in the protozoan parasite Leishmania major. Biol Chem 1997; 272: 13883–91.",
            "process_entry": "True",
            "xmlid": "CIT0056"
        },
        {
            "bibentry": "Brodelius, PE. Enzyme assays. Curr Opin Biotechnol 1991; 2: 23–9. PMID: 1367706",
            "process_entry": "True",
            "doi": "10.1016/0958-1669(91)90057-c",
            "pmid": "1367706",
            "xmlid": "CIT0057"
        },
        {
            "bibentry": "Caldwell, GW, Yan, Z, Lang, W, Masucci, JA. The IC(50) concept revisited. Curr Top Med Chem 2012; 12: 1282–90. PMID: 22571790",
            "process_entry": "True",
            "doi": "10.2174/156802612800672844",
            "pmid": "22571790",
            "xmlid": "CIT0058"
        },
        {
            "bibentry": "Stone, SR, Morrison, JF. Dihydrofolate reductase from Escherichia coli: the kinetic mechanism with NADPH and reduced acetylpyridine adenine dinucleotide phosphate as substrates. Biochemistry 1988; 27: 5493–9. PMID: 3052577",
            "process_entry": "True",
            "doi": "10.1021/bi00415a016",
            "pmid": "3052577",
            "xmlid": "CIT0059"
        },
        {
            "bibentry": "Nammalwar, B, Bunce, RA, Berlin, KD, et al. Microwave-assisted heck synthesis of substituted 2,4-diaminopyrimidine-based antibiotics. Org Prep Proced Int 2012; 44: 281–7. PMID: 23805009",
            "process_entry": "True",
            "doi": "10.1080/00304948.2012.676823",
            "pmid": "23805009",
            "pmcid": "PMC3691060",
            "xmlid": "CIT0060"
        }
    ],
    "localid": "MED-31409157",
    "doi": "10.1080/14756366.2019.1651311",
    "pmid": "10.1080/14756366.2019.1651311",
    "pmcid": "31409157",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/31409157/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,176)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),178,162)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),341,148)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),490,268)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),759,182)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0007",
                "rp_string": "7–9",
                "pl_string": "Leishmaniasis is an infectious disease caused by several species of the genus Leishmania, which are responsible for its different epidemiological and clinical characteristics1. Visceral leishmaniasis (VL), the most severe clinical form of leishmaniasis, affects 300,000 people worldwide, 90% of whom would die if no treatment is provided2. The available drugs to fight this disease have been in the market for more than 40 years and for that reason, resistant strains have been selected3. On top of that, N-methyl glucamine (Glucantime®), the drug of choice to treat patients with leishmaniasis, may cause nephrotoxicity, anorexia, abdominal pain, lethargy and cardiotoxicity4 and the second-choice drug (amphotericin B) shows cardiac and nephron toxicity5. Although two new drug candidates to treat VL entered clinical tests in 20176, the search for new safe, effective, oral, short-course leishmanicidal agents continues to be a priority. In order to achieve this goal, several efforts have been made to develop compounds that inhibit carbonic anhydrase7–9, arginase10, or enzymes that protect the parasite from the oxidative stress11,12.",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[7]",
                "pl_xpath": "/article/body/sec[1]/p[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),942,199)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 6,
                "xref_id": "CIT0008",
                "pl_string": "7–9",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),942,199)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 7,
                "xref_id": "CIT0009",
                "pl_string": "7–9",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),942,199)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0007",
                "rp_string": "7–9",
                "pl_string": "Leishmaniasis is an infectious disease caused by several species of the genus Leishmania, which are responsible for its different epidemiological and clinical characteristics1. Visceral leishmaniasis (VL), the most severe clinical form of leishmaniasis, affects 300,000 people worldwide, 90% of whom would die if no treatment is provided2. The available drugs to fight this disease have been in the market for more than 40 years and for that reason, resistant strains have been selected3. On top of that, N-methyl glucamine (Glucantime®), the drug of choice to treat patients with leishmaniasis, may cause nephrotoxicity, anorexia, abdominal pain, lethargy and cardiotoxicity4 and the second-choice drug (amphotericin B) shows cardiac and nephron toxicity5. Although two new drug candidates to treat VL entered clinical tests in 20176, the search for new safe, effective, oral, short-course leishmanicidal agents continues to be a priority. In order to achieve this goal, several efforts have been made to develop compounds that inhibit carbonic anhydrase7–9, arginase10, or enzymes that protect the parasite from the oxidative stress11,12.",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[7]",
                "pl_xpath": "/article/body/sec[1]/p[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),942,199)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 9,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),942,199)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Leishmaniasis is an infectious disease caused by several species of the genus Leishmania, which are responsible for its different epidemiological and clinical characteristics1. Visceral leishmaniasis (VL), the most severe clinical form of leishmaniasis, affects 300,000 people worldwide, 90% of whom would die if no treatment is provided2. The available drugs to fight this disease have been in the market for more than 40 years and for that reason, resistant strains have been selected3. On top of that, N-methyl glucamine (Glucantime®), the drug of choice to treat patients with leishmaniasis, may cause nephrotoxicity, anorexia, abdominal pain, lethargy and cardiotoxicity4 and the second-choice drug (amphotericin B) shows cardiac and nephron toxicity5. Although two new drug candidates to treat VL entered clinical tests in 20176, the search for new safe, effective, oral, short-course leishmanicidal agents continues to be a priority. In order to achieve this goal, several efforts have been made to develop compounds that inhibit carbonic anhydrase7–9, arginase10, or enzymes that protect the parasite from the oxidative stress11,12.",
                "pl_xpath": "/article/body/sec[1]/p[1]"
            },
            {
                "n_rp": 10,
                "xref_id": "CIT0011",
                "rp_string": "11",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),942,199)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Leishmaniasis is an infectious disease caused by several species of the genus Leishmania, which are responsible for its different epidemiological and clinical characteristics1. Visceral leishmaniasis (VL), the most severe clinical form of leishmaniasis, affects 300,000 people worldwide, 90% of whom would die if no treatment is provided2. The available drugs to fight this disease have been in the market for more than 40 years and for that reason, resistant strains have been selected3. On top of that, N-methyl glucamine (Glucantime®), the drug of choice to treat patients with leishmaniasis, may cause nephrotoxicity, anorexia, abdominal pain, lethargy and cardiotoxicity4 and the second-choice drug (amphotericin B) shows cardiac and nephron toxicity5. Although two new drug candidates to treat VL entered clinical tests in 20176, the search for new safe, effective, oral, short-course leishmanicidal agents continues to be a priority. In order to achieve this goal, several efforts have been made to develop compounds that inhibit carbonic anhydrase7–9, arginase10, or enzymes that protect the parasite from the oxidative stress11,12.",
                "pl_xpath": "/article/body/sec[1]/p[1]"
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0012",
                "rp_string": "12",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),942,199)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,175)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Trypanosomatids dependence on host-synthesized purine and pteridines has long been targeted to fight Chagas disease13, human African trypanosomiasis14, and leishmaniasis15,16. Among the enzymes that play a key role in the salvage and folate pathway, dihydrofolate reductase is the macromolecular target of several drugs, including those available to fight malaria17. However, the selection of pyrimethamine-resistant Plasmodium falciparum strains underscores the risks of blocking a single target from this pathway18. Single point mutations19, as well as biochemical pathway plasticity17,20, can significantly reduce the drug effectiveness. In fact, a bypass mechanism explains why Leishmania parasites have low susceptibility to methotrexate or trimethoprim21–23, despite the fact that DHFR-TS gene knockout is lethal to the Leishmania parasites24.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 13,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,175)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Trypanosomatids dependence on host-synthesized purine and pteridines has long been targeted to fight Chagas disease13, human African trypanosomiasis14, and leishmaniasis15,16. Among the enzymes that play a key role in the salvage and folate pathway, dihydrofolate reductase is the macromolecular target of several drugs, including those available to fight malaria17. However, the selection of pyrimethamine-resistant Plasmodium falciparum strains underscores the risks of blocking a single target from this pathway18. Single point mutations19, as well as biochemical pathway plasticity17,20, can significantly reduce the drug effectiveness. In fact, a bypass mechanism explains why Leishmania parasites have low susceptibility to methotrexate or trimethoprim21–23, despite the fact that DHFR-TS gene knockout is lethal to the Leishmania parasites24.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 14,
                "xref_id": "CIT0015",
                "rp_string": "15",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,175)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Trypanosomatids dependence on host-synthesized purine and pteridines has long been targeted to fight Chagas disease13, human African trypanosomiasis14, and leishmaniasis15,16. Among the enzymes that play a key role in the salvage and folate pathway, dihydrofolate reductase is the macromolecular target of several drugs, including those available to fight malaria17. However, the selection of pyrimethamine-resistant Plasmodium falciparum strains underscores the risks of blocking a single target from this pathway18. Single point mutations19, as well as biochemical pathway plasticity17,20, can significantly reduce the drug effectiveness. In fact, a bypass mechanism explains why Leishmania parasites have low susceptibility to methotrexate or trimethoprim21–23, despite the fact that DHFR-TS gene knockout is lethal to the Leishmania parasites24.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            }
        ],
        [
            {
                "n_rp": 15,
                "xref_id": "CIT0016",
                "rp_string": "16",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,175)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 16,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),177,190)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 17,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),368,150)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 18,
                "xref_id": "CIT0019",
                "rp_string": "19",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),519,122)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 19,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),519,122)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_xpath": "substring(string(/article/body/sec[1]/p[2]),585,5)",
                "pl_string": "y17,2"
            },
            {
                "n_rp": 20,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),519,122)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_xpath": "substring(string(/article/body/sec[1]/p[2]),585,5)",
                "pl_string": "y17,2"
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0021",
                "rp_string": "21–23",
                "pl_string": "Trypanosomatids dependence on host-synthesized purine and pteridines has long been targeted to fight Chagas disease13, human African trypanosomiasis14, and leishmaniasis15,16. Among the enzymes that play a key role in the salvage and folate pathway, dihydrofolate reductase is the macromolecular target of several drugs, including those available to fight malaria17. However, the selection of pyrimethamine-resistant Plasmodium falciparum strains underscores the risks of blocking a single target from this pathway18. Single point mutations19, as well as biochemical pathway plasticity17,20, can significantly reduce the drug effectiveness. In fact, a bypass mechanism explains why Leishmania parasites have low susceptibility to methotrexate or trimethoprim21–23, despite the fact that DHFR-TS gene knockout is lethal to the Leishmania parasites24.",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[10]",
                "pl_xpath": "/article/body/sec[1]/p[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),642,208)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 22,
                "xref_id": "CIT0022",
                "pl_string": "21–23",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),642,208)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 23,
                "xref_id": "CIT0023",
                "pl_string": "21–23",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),642,208)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0021",
                "rp_string": "21–23",
                "pl_string": "Trypanosomatids dependence on host-synthesized purine and pteridines has long been targeted to fight Chagas disease13, human African trypanosomiasis14, and leishmaniasis15,16. Among the enzymes that play a key role in the salvage and folate pathway, dihydrofolate reductase is the macromolecular target of several drugs, including those available to fight malaria17. However, the selection of pyrimethamine-resistant Plasmodium falciparum strains underscores the risks of blocking a single target from this pathway18. Single point mutations19, as well as biochemical pathway plasticity17,20, can significantly reduce the drug effectiveness. In fact, a bypass mechanism explains why Leishmania parasites have low susceptibility to methotrexate or trimethoprim21–23, despite the fact that DHFR-TS gene knockout is lethal to the Leishmania parasites24.",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[10]",
                "pl_xpath": "/article/body/sec[1]/p[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),642,208)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 25,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),642,208)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Trypanosomatids dependence on host-synthesized purine and pteridines has long been targeted to fight Chagas disease13, human African trypanosomiasis14, and leishmaniasis15,16. Among the enzymes that play a key role in the salvage and folate pathway, dihydrofolate reductase is the macromolecular target of several drugs, including those available to fight malaria17. However, the selection of pyrimethamine-resistant Plasmodium falciparum strains underscores the risks of blocking a single target from this pathway18. Single point mutations19, as well as biochemical pathway plasticity17,20, can significantly reduce the drug effectiveness. In fact, a bypass mechanism explains why Leishmania parasites have low susceptibility to methotrexate or trimethoprim21–23, despite the fact that DHFR-TS gene knockout is lethal to the Leishmania parasites24.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            }
        ],
        [
            {
                "n_rp": 26,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,199)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 27,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),201,120)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),322,224)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 29,
                "xref_id": "CIT0015",
                "rp_string": "15",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),547,120)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 30,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),547,120)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 31,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),547,120)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 32,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),248,283)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),190,270)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 34,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p),1,86)",
                "containers_title": [
                    "Materials and methods",
                    "Synthesis of 2,4-diaminopyrimidines"
                ]
            }
        ],
        [
            {
                "n_rp": 35,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[3]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[3]),226,300)",
                "containers_title": [
                    "Materials and methods",
                    "Cloning of the enzyme LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 36,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),410,116)",
                "containers_title": [
                    "Materials and methods",
                    "Cloning of the enzyme LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p[4]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p[4]),1,120)",
                "containers_title": [
                    "Materials and methods",
                    "Expression and purification of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 38,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[6]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[6]),294,104)",
                "containers_title": [
                    "Materials and methods",
                    "Cloning of LcDHFR coding gene into E. coli ArticExpress (DE3) cells"
                ]
            }
        ],
        [
            {
                "n_rp": 39,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[2]/sec[5]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[5]/p[2]),391,125)",
                "containers_title": [
                    "Materials and methods",
                    "Expression and purification of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 40,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[2]/sec[5]/p[3]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[5]/p[3]),859,91)",
                "containers_title": [
                    "Materials and methods",
                    "Expression and purification of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 41,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[2]/sec[6]/sec[1]/p[1]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[6]/sec[1]/p[1]),1,99)",
                "containers_title": [
                    "Materials and methods",
                    "Kinetic studies with LcDHFR-TS and LcPTR1",
                    "LcDHFR-TS apparent Km determination"
                ]
            }
        ],
        [
            {
                "n_rp": 42,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[2]/sec[6]/sec[2]/p[1]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[6]/sec[2]/p[1]),1,148)",
                "containers_title": [
                    "Materials and methods",
                    "Kinetic studies with LcDHFR-TS and LcPTR1",
                    "LcPTR1 apparent Km determination"
                ]
            }
        ],
        [
            {
                "n_rp": 43,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[2]/sec[6]/sec[5]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[6]/sec[5]/p[2]),473,458)",
                "containers_title": [
                    "Materials and methods",
                    "Kinetic studies with LcDHFR-TS and LcPTR1",
                    "Determination of the inhibition mechanism"
                ]
            }
        ],
        [
            {
                "n_rp": 44,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[3]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[3]),75,98)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression, and purification of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[4]),1,273)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression, and purification of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 46,
                "xref_id": "CIT0036",
                "rp_string": "36",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[5]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[5]),121,165)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression, and purification of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 47,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[2]),183,177)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression and purification of LcDHFR-TS"
                ],
                "pl_string": "This strategy allows the expression of the recombinant protein fused to His-tag in the N-terminal domain to facilitate its purification through nickel resin affinity chromatography. The same N-terminal His-tag fusion strategy was successfully employed in the cloning, expression, and purification of Leishmania (Vianna) braziliensis37, and T. cruzi DHFR-TS38.",
                "pl_xpath": "/article/body/sec[3]/sec[2]/p[2]"
            },
            {
                "n_rp": 48,
                "xref_id": "CIT0038",
                "rp_string": "38",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[2]),183,177)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression and purification of LcDHFR-TS"
                ],
                "pl_string": "This strategy allows the expression of the recombinant protein fused to His-tag in the N-terminal domain to facilitate its purification through nickel resin affinity chromatography. The same N-terminal His-tag fusion strategy was successfully employed in the cloning, expression, and purification of Leishmania (Vianna) braziliensis37, and T. cruzi DHFR-TS38.",
                "pl_xpath": "/article/body/sec[3]/sec[2]/p[2]"
            }
        ],
        [
            {
                "n_rp": 49,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),356,90)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression and purification of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 50,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),447,164)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression and purification of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 51,
                "xref_id": "CIT0041",
                "rp_string": "41",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),794,122)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression and purification of LcDHFR-TS"
                ],
                "pl_string": "(T. brucei DHFR-TS41,42, L. tropica DHFR-TS31, and L. major DHFR-TS39)",
                "pl_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),845,70)"
            },
            {
                "n_rp": 52,
                "xref_id": "CIT0042",
                "rp_string": "42",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[3]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),794,122)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression and purification of LcDHFR-TS"
                ],
                "pl_string": "(T. brucei DHFR-TS41,42, L. tropica DHFR-TS31, and L. major DHFR-TS39)",
                "pl_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),845,70)"
            },
            {
                "n_rp": 53,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[3]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),794,122)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression and purification of LcDHFR-TS"
                ],
                "pl_string": "(T. brucei DHFR-TS41,42, L. tropica DHFR-TS31, and L. major DHFR-TS39)",
                "pl_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),845,70)"
            },
            {
                "n_rp": 54,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[3]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),794,122)",
                "containers_title": [
                    "Results and discussion",
                    "Cloning, expression and purification of LcDHFR-TS"
                ],
                "pl_string": "(T. brucei DHFR-TS41,42, L. tropica DHFR-TS31, and L. major DHFR-TS39)",
                "pl_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),845,70)"
            }
        ],
        [
            {
                "n_rp": 55,
                "xref_id": "CIT0043",
                "rp_string": "43",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[2]),1,305)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 56,
                "xref_id": "CIT0044",
                "rp_string": "44",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[4]),1,263)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 57,
                "xref_id": "CIT0045",
                "rp_string": "45",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[4]),265,151)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 58,
                "xref_id": "CIT0041",
                "rp_string": "41",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[4]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[4]),417,138)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 59,
                "xref_id": "CIT0048",
                "rp_string": "48",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[4]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[4]),556,132)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 60,
                "xref_id": "CIT0049",
                "rp_string": "49",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[5]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[5]),1,296)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 61,
                "xref_id": "CIT0050",
                "rp_string": "50",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[6]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[6]),97,316)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 62,
                "xref_id": "CIT0051",
                "rp_string": "51",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[6]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[6]),414,286)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ],
                "pl_string": "Once reaction conditions were standardized, we proceeded to LcDHFR-TS kinetic characterization. Determination of kinetic parameters is crucial to the standardization of assay conditions for inhibitors screening50 since cofactor and substrate concentrations must be close to the Km apparent in the assay to allow identification of different inhibitors modalities: competitive, noncompetitive, and uncompetitive43. As an ordered bi-random mechanism is described to the formation of DHFR • NADPH • DHF complex51, the simplifications described by Michaelian kinetics can be applied for the LcDHFR-TS by maintaining saturating conditions of one substrate to allow kinetic characterization of the other33.",
                "pl_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[6]"
            },
            {
                "n_rp": 63,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[6]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[6]),414,286)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ],
                "pl_string": "Once reaction conditions were standardized, we proceeded to LcDHFR-TS kinetic characterization. Determination of kinetic parameters is crucial to the standardization of assay conditions for inhibitors screening50 since cofactor and substrate concentrations must be close to the Km apparent in the assay to allow identification of different inhibitors modalities: competitive, noncompetitive, and uncompetitive43. As an ordered bi-random mechanism is described to the formation of DHFR • NADPH • DHF complex51, the simplifications described by Michaelian kinetics can be applied for the LcDHFR-TS by maintaining saturating conditions of one substrate to allow kinetic characterization of the other33.",
                "pl_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[6]"
            }
        ],
        [
            {
                "n_rp": 64,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[7]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[7]),230,323)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 65,
                "xref_id": "CIT0052",
                "rp_string": "52",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[8]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[8]),1,106)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 66,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[1]/p[8]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[1]/p[8]),108,170)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcDHFR-TS"
                ]
            }
        ],
        [
            {
                "n_rp": 67,
                "xref_id": "CIT0053",
                "rp_string": "53",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[2]),353,104)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 68,
                "xref_id": "CIT0052",
                "rp_string": "52",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[3]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[3]),229,249)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 69,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[4]),1,382)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ],
                "pl_string": "Accordingly, as PTR1 presents an ordered mechanism of PTR1•NADPH•BPT complex formation23, in which the substrate (BPT) only binds the enzyme after formation of PTR1•NADPH, it is possible for the use of the Michaelian simplifications for the kinetic characterization of LcPTR1 by maintaining saturating conditions for BPT to enable the determination of cofactor Km, and vice versa33.",
                "pl_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[4]"
            },
            {
                "n_rp": 70,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[4]),1,382)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ],
                "pl_string": "Accordingly, as PTR1 presents an ordered mechanism of PTR1•NADPH•BPT complex formation23, in which the substrate (BPT) only binds the enzyme after formation of PTR1•NADPH, it is possible for the use of the Michaelian simplifications for the kinetic characterization of LcPTR1 by maintaining saturating conditions for BPT to enable the determination of cofactor Km, and vice versa33.",
                "pl_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[4]"
            }
        ],
        [
            {
                "n_rp": 71,
                "xref_id": "CIT0054",
                "rp_string": "54",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[5]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[5]),240,87)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 72,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[5]),328,241)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 73,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[6]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[6]),1,304)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 74,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[7]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[7]),1,159)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 75,
                "xref_id": "CIT0055",
                "rp_string": "55",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[7]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[7]),161,212)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 76,
                "xref_id": "CIT0050",
                "rp_string": "50",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[8]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[8]),263,115)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 77,
                "xref_id": "CIT0056",
                "rp_string": "56",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[8]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[8]),379,236)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 78,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[2]/p[9]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[2]/p[9]),269,172)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "Catalytic activity of LcPTR1"
                ]
            }
        ],
        [
            {
                "n_rp": 79,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[3]/p[1]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[3]/p[1]),1,297)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "LcPTR1 and LcDHFR inhibition assays"
                ]
            }
        ],
        [
            {
                "n_rp": 80,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[3]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[3]/p[2]),1,306)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "LcPTR1 and LcDHFR inhibition assays"
                ]
            }
        ],
        [
            {
                "n_rp": 81,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[3]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[3]/p[2]),1,306)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "LcPTR1 and LcDHFR inhibition assays"
                ]
            }
        ],
        [
            {
                "n_rp": 82,
                "xref_id": "CIT0057",
                "rp_string": "57",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[3]/p[4]/sup/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[3]/p[4]),1,243)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "LcPTR1 and LcDHFR inhibition assays"
                ],
                "pl_string": "57",
                "pl_xpath": "/article/body/sec[3]/sec[3]/sec[3]/p[4]/sup"
            }
        ],
        [
            {
                "n_rp": 83,
                "xref_id": "CIT0058",
                "rp_string": "58",
                "rp_xpath": "/article/body/sec[3]/sec[3]/sec[3]/p[4]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/sec[3]/p[4]),1,243)",
                "containers_title": [
                    "Results and discussion",
                    "Kinetic characterization of LcDHFR-TS and LcPTR1",
                    "LcPTR1 and LcDHFR inhibition assays"
                ]
            }
        ],
        [
            {
                "n_rp": 84,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p[2]),1,219)",
                "containers_title": [
                    "Results and discussion",
                    "Mechanism of inhibition assays"
                ]
            }
        ],
        [
            {
                "n_rp": 85,
                "xref_id": "CIT0059",
                "rp_string": "59",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p[8]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p[8]),1,167)",
                "containers_title": [
                    "Results and discussion",
                    "Mechanism of inhibition assays"
                ]
            }
        ],
        [
            {
                "n_rp": 86,
                "xref_id": "CIT0060",
                "rp_string": "60",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p[8]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p[8]),169,94)",
                "containers_title": [
                    "Results and discussion",
                    "Mechanism of inhibition assays"
                ]
            }
        ],
        [
            {
                "n_rp": 87,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p[8]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p[8]),264,202)",
                "containers_title": [
                    "Results and discussion",
                    "Mechanism of inhibition assays"
                ]
            }
        ],
        [
            {
                "n_rp": 88,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[2]),248,216)",
                "containers_title": [
                    "Results and discussion",
                    "Selective and dual inhibitors"
                ]
            }
        ],
        [
            {
                "n_rp": 89,
                "xref_id": "CIT0050",
                "rp_string": "50",
                "rp_xpath": "/article/body/sec[3]/sec[5]/table-wrap/table-wrap-foot/fn[1]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/table-wrap/table-wrap-foot/fn[1]/p),1,40)",
                "containers_title": [
                    "Results and discussion",
                    "Selective and dual inhibitors"
                ]
            }
        ],
        [
            {
                "n_rp": 90,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[3]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[3]),254,209)",
                "containers_title": [
                    "Results and discussion",
                    "Selective and dual inhibitors"
                ]
            }
        ]
    ]
}